Patents by Inventor Veronica Gibaja

Veronica Gibaja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210260040
    Abstract: The present disclosure relates to a method of preventing or treating a blood disorder (e.g., sickle-cell disease) via administering an EHMT2 inhibitor compound disclosed herein or a pharmaceutical composition thereof to subjects in need thereof. The present disclosure also relates to the use of such compounds for research or other non-therapeutic purposes.
    Type: Application
    Filed: October 18, 2018
    Publication date: August 26, 2021
    Inventors: Elayne PENEBRE, Veronica GIBAJA, Maria Alejandra RAIMONDI
  • Publication number: 20160091485
    Abstract: The invention provides methods of detecting an EZH2 mutation and associated epigenetic markers in a cancer cell, methods cancer diagnosis and methods of screening for EZH2 inhibitors.
    Type: Application
    Filed: April 11, 2014
    Publication date: March 31, 2016
    Applicants: THE BROAD INSTITUTE, INC., NOVARTIS AG
    Inventors: Ho Man CHAN, Veronica GIBAJA, Kristy HAAS, Jacob JAFFE, Mariela JASKELIOFF, Frank Peter STEGMEIER, Wei QI
  • Patent number: 6642033
    Abstract: Disclosed are nucleic acids that can be used as probes for detecting parvovirus in a sample of nucleic acid molecules. The nucleic acids hybridize to regions encoding a non- structural protein or structural proteins of human parvovirus strain 19 or porcine parvovirus. Also disclosed are methods for detecting and amplifying parvovirus in a sample using the nucleic acids of the invention.
    Type: Grant
    Filed: July 19, 2000
    Date of Patent: November 4, 2003
    Assignee: V.I. Technologies, Inc.
    Inventors: Aristides Lazo, Xiaojuan Zhao, Jodie Ann Tassello, Veronica Gibaja